Visual short-term memory binding and attentional processes during object-scene integration are preserved in mild cognitive impairment
Cortex · 2025
DOI: 10.1016/j.cortex.2024.12.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cortex, 2025. Verfasst von Elena Allegretti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Attention, Memory, Short-Term, Visual Perception. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology, Leverhulme Trust.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, Sapienza University of Rome, Rome, Italy.
- Department of Psychology, Sapienza University of Rome, Rome, Italy; IRCCS Fondazione Santa Lucia, Rome, Italy.
- Department of Psychology, Sapienza University of Rome, Rome, Italy; IRCCS Fondazione Santa Lucia, Rome, Italy. Electronic address: moreno.coco@uniroma1.it.
Förderung
- Foundation for Science and Technology
- Leverhulme Trust
Zitieren
APA
Allegretti, E., Mauti, M., & Coco, M. I. (2025). Visual short-term memory binding and attentional processes during object-scene integration are preserved in mild cognitive impairment. Cortex. https://doi.org/10.1016/j.cortex.2024.12.002
Vancouver
Allegretti E, Mauti M, Coco MI. Visual short-term memory binding and attentional processes during object-scene integration are preserved in mild cognitive impairment. Cortex. 2025. doi:10.1016/j.cortex.2024.12.002
BibTeX
@article{Allegretti2025,
author = {Allegretti, Elena and Mauti, Marika and Coco, Moreno I},
title = {Visual short-term memory binding and attentional processes during object-scene integration are preserved in mild cognitive impairment},
journal = {Cortex},
year = {2025},
doi = {10.1016/j.cortex.2024.12.002}
}
EUVIMED